Oral VK2735
A Phase 1 Study of VK2735 in Obese Adults Without Comorbidities
Viking Therapeutics · Phase 1 · Recruiting · Enrollment 270
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 2 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 3 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 4 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 5 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 6 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 7 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 8 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 9 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 10 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 11 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 12 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 14 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 15 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 16 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 17 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 18 | Obese Adults | n/r | n/r | n/r | n/r |
| VK2735 Dose Level 13 | Obese Adults | n/r | n/r | n/r | n/r |